Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium plantarum and Increased Short-Chain Fatty Acid Production

Research synthesisVery low evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies (all in vitro or ex vivo fermentation models), all reported beneficial effects on short-chain fatty acid (SCFA) production, with a predominant effect size of moderate (3 of 4 studies showing moderate effects; 1 small). No consistent dose or duration was reported, and no human clinical trials were identified. These findings suggest a potential role for Bifidobacterium plantarum strains in enhancing SCFA production, but the evidence is preliminary.

Caveats: Available evidence is overwhelmingly positive (4 of 4 studies beneficial) — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. All studies were conducted in vitro or using fecal fermentation models, not in human subjects; human clinical trials are needed to confirm relevance.

Generated Jun 11, 2026
5 of 5 papers
Back to top